Hondaet al
(2001) Spinorphin, an endogenous inhibitor of enkephalin-degrading enzymes,
potentiates Leu-enkephalin-induced anti-allodynic and antinociceptive effects
in mice. Jpn.J.Pharmacol. 87 261. Lianget al
(2001) The endogenous opioid spinorphin blocks fMet-Leu-Phe-induced neutrophil
chemotaxis by acting as a specific antagonist at the N-formylpeptide
receptor subtype FPR. J.Immunol. 167 6609. Junget al
(2007) Structure-activity relationship studies of spinorphin as a potent and
selective human P2X3 receptor antagonist. J.Med.Chem. 50
4543.